These outcomes, together with a former report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 help the notion of targeting ACKR3 as a unique approach to modulate the opioid process, which could open new therapeutic avenues for opioid-related Ailments. Researchers believe that blocking this scavenger https://elizabethh371urt1.wiki-cms.com/user